Cord blood banking is an emerging field in the biosciences industry. Although research concerning the stem cells that can be derived from umbilical cord blood started during the early 1990s, it is only during the past decade that doctors at cord blood banks like Insception Biosciences have been putting the technology to use.
Cord blood is a rich source of stem cells, which can be used to treat a wide variety of cancers, immunodeficiency’s, bone marrow failure syndromes and blood disorders. The list of diseases that can be treated with cord blood contains over 75 names, and continues to grow as researchers discover more applications.
The only other approved source of stem cell is bone marrow, but the process of collection and transplantation can be quite painful for the donor and the recipient. Additionally, the stem cells found in cord blood are younger and more adaptable, so a perfect match is not needed. Cord blood can therefore be used on the donor, their immediate family or an unrelated individual who is a match for their sample. This makes cord blood a more widely applicable treatment option than bone marrow.
There are two popular options for the storing of cord blood: donation or banking. While donation is a much more affordable option, it is less secure than storing cord blood in a family bank such as Insception. When donating your child’s cord blood to a registry, it becomes available to the first child who needs a transplant, so if the donor child becomes ill, they must find a new donor. In many cases, banks dispose of a percentage of their units, deeming them useless. On the other hand, a family cord blood bank holds the unit until the donor’s parents request it for a family member’s transplant.
Expecting parents are urged to speak with their family doctor about cord blood banking at least six months before their due date. Their doctor can then arrange for the parents to take the necessary steps to storing their child’s cord blood.
To provide more information on the topic, two cord blood experts from Insception’s research and medical team will be joining ParentGuide.ca as contributors. Dr. Ian Rogers’ focus is the application of umbilical cord blood in the treatment of various diseases, as his lab continues to develop cord blood treatments for blood and vascular diseases. Dr. Robert Casper is the founder and Medical Director of Insception Biosciences. He has authored more than 275 articles, earning him the Canadian Fertility and Andrology Society. With their expertise, readers of ParentGuide.ca will obtain an informative and well-rounded perspective on cord blood banking and the technology behind it.
Thank you to Insception Biosciences